Publication | Closed Access
Safety and efficacy of teneligliptin: a novel DPP-4 inhibitor for hemodialysis patients with type 2 diabetes
48
Citations
11
References
2013
Year
HemodialysisRenal FunctionHemodialysis PatientsNovel Dpp-4 InhibitorKidney FailureChronic Kidney DiseasePharmacologyDiabetesType 2Diabetic Kidney DiseaseDialysis TherapyMedicineNephrology
| Year | Citations | |
|---|---|---|
Page 1
Page 1